Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06645613 · ClinicalTrials.gov registry record · NA

TMS With Real-time E-field and EEG Source Imaging

A NA study, sponsored by Brigham and Women's Hospital.

Active
Registry status
NA
Development phase
50
Enrollment target

NCT06645613 is a NA study that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06645613, a NA study, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The goal of this study is to develop and validate an approach for accurate targeting and stimulation of brain networks using transcranial magnetic stimulation (TMS) using information from magnetic resonance imaging (MRI) data. This study requires two visits from each participant. In the first visit, the participant will be scanned by MRI scanners to collect data from the brain. Next, the data will be analyzed by the researcher to model the connections between different regions of the brain to determine the stimulation areas related to the so-called frontoparietal network. In the second visit, the participants will take four TMS sessions with different types of stimulations applied to the computed targets and complete a computer-based task named multi-source interference task. Electroencephalogram (EEG) data will be collected during the TMS stimulations and tasks. The main hypothesis is that applying TMS stimulations to the brain targets reduces the response time and response error in the tasks.

Interventions

  • DEVICE Transcranial Magnetic Stimulation Device

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-03-01
Est. Completion 2029-09-01
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT06645613

The ClinicalTrials.gov registry entry for NCT06645613 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Transcranial Magnetic Stimulation Device is the first listed.

NCT06645613 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06645613 about?

NCT06645613 is a clinical study titled "TMS With Real-time E-field and EEG Source Imaging". The goal of this study is to develop and validate an approach for accurate targeting and stimulation of brain networks using transcranial magnetic stimulation (TMS) using information from magnetic resonance imaging (MRI) data. This study requires two visits from each participant. In the first visit...

What is the current status of trial NCT06645613?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-03-01. Estimated completion is 2029-09-01.

What interventions are being tested in trial NCT06645613?

The interventions under investigation include: Transcranial Magnetic Stimulation Device (DEVICE).

Who is sponsoring clinical trial NCT06645613?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.